BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6355750)

  • 1. [Monitoring glucose tolerance and blood insulin in patients with chronic liver disease with a 5 year clinical history].
    Oehler G; Bleyl H; Matthes K
    Med Welt; 1983 Sep; 34(37):995-7. PubMed ID: 6355750
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on glucose tolerance, serum insulin and free fatty acid in chronic liver disease.
    Parida RK; Santhalia RR; Mishra PK; Pradhan N; Samal KC; Sahoo CS
    J Assoc Physicians India; 1981 Feb; 29(2):119-27. PubMed ID: 7021524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in blood sugar and blood insulin chronic liver diseases].
    Chiti E; Greco GM
    Minerva Med; 1982 Dec; 73(49-50):3495-8. PubMed ID: 6759984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma insulin, glucose and C-peptide responses to oral glucose tolerance test in patients with liver disease].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):657-61. PubMed ID: 6819876
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum insulin levels and blood glucose after oral glucose loading in chronic liver patients with normal and with increased body weight].
    Oehler G; Bleyl H; Schmahl FW; Matthes K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1403-6. PubMed ID: 611854
    [No Abstract]   [Full Text] [Related]  

  • 6. The serum level of certain aminoacids in chronic liver diseases associated with impaired oral glucose tolerance.
    Sâmpelean D; Grigorescu M; Jebeleanu G; Vlad C
    Rom J Intern Med; 2006; 44(1):79-84. PubMed ID: 17236290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance and insulin resistance in patients with liver disease.
    Collins JR; Crofford OB
    Arch Intern Med; 1969 Aug; 124(2):142-8. PubMed ID: 5797072
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoreactive insulin in schistosomal hepatic fibrosis.
    Nofal M; el-Sawy M
    J Trop Med Hyg; 1973 Jan; 76(1):16-8. PubMed ID: 4684162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assessment of carbohydrate metabolism changes in children with diseases of the gastrointestinal tract and liver].
    Arsen'eva EN
    Vopr Okhr Materin Det; 1977; 22(2):20-2. PubMed ID: 841938
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood sugar and blood insulin levels in duodenal peptic ulcer].
    Shvarts VIa; Saakian AG; Frolkov VK; Kuznetsov BG
    Klin Med (Mosk); 1982 Feb; 60(2):40-4. PubMed ID: 7040795
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma insulin response to oral glucose in liver cirrhosis.
    Toccafondi R; Palmas S; Maioli M
    Riv Crit Clin Med; 1970; 70(1):110-9. PubMed ID: 5527337
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma immuno-reactive insulin (IRI) and peripherel glucose utilization in bilharzial patients with impaired renal functions.
    El-Badry A; Hassaballah AM; El-Ayadi A; Barsoum RS; Shaheen MH; El-Ghoneimy EH; Abdel-Rahman Y; El-Bagoury I
    J Egypt Med Assoc; 1975; 58(7-8):361-9. PubMed ID: 1236509
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
    Oehler G; Bleyl H; Knecht M; Matthes K
    Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation.
    Stockmann M; Konrad T; Nolting S; Hünerbein D; Wernecke KD; Döbling H; Steinmüller T; Neuhaus P
    Liver Transpl; 2006 Apr; 12(4):535-43. PubMed ID: 16496277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between blood insulin response and blood potassium changes during oral glucose load (preliminary note)].
    Strollo G; Morè M; Di Pietro S; Di Cesare T; Peruzzi AM; Semprini A
    Boll Soc Ital Biol Sper; 1981 Oct; 57(20):2022-8. PubMed ID: 7032544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.
    Chang AM; Smith MJ; Bloem CJ; Galecki AT; Halter JB
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E906-11. PubMed ID: 15213063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of phentolamine on the glucose metabolism in normal persons and patients with chronic kidney insufficiency].
    Spath P; Dittrich P; Sailer S; Sandhofer F
    Wien Z Inn Med; 1970; 51(9):437-45. PubMed ID: 4332691
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of total insulin activity and the content of free insulin in the blood in chronic diffuse liver diseases].
    Rostomova LT; Kurashvili RB
    Ter Arkh; 1974; 46(12):87-90. PubMed ID: 4454029
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.